SCHEMBL559406

SCHEMBL559406

CCOC(OCC)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.46
THRB P10828 1/20 0.40
LMNA P02545 3/20 0.38
ALDH1A1 P00352 3/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CYP1A2 P05177 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33
CAD P27708 1/20 0.32
PARP10 Q53GL7 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27789246 0.85
SCHEMBL4283577 0.84 ALOX15 (0.34) ALOX15ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL13485048 0.80 ALOX15 (0.43) ALOX15THRBLMNAALDH1A1CA1
SCHEMBL4283583 0.79 LMNA (0.39) ALOX15LMNA
SCHEMBL2078307 0.78
SCHEMBL4321838 0.78
SCHEMBL3028808 0.76
SCHEMBL6395180 0.76
Isobutyramide SCHEMBL2428256 0.76 LMNA (0.60) ALOX15THRBLMNAALDH1A1CA1
SCHEMBL13485057 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178840-B Polypropylene composite material and preparation method and application thereof 金发科技股份有限公司 2024-06-04 CN claimed
CN-116178840-A Polypropylene composite material and preparation method and application thereof 金发科技股份有限公司 2023-05-30 CN claimed
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US claimed
WO-2021113489-A1 POLYAMIC ACID VARNISH FROM HIGH PURITY BISPHENOL A DIANHYDRIDE AND ARTICLES PREPARED THEREFROM SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2021-06-10 WO claimed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US claimed
US-10604850-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-31 US claimed
CN-110423227-A A kind of synthetic method of 2- formoxyl -4- carboxylic acid, ethyl ester thiazole SUZHOU HANDE CHUANGHONG BIOCHEMISTRY TECH CO LTD 2019-11-08 CN claimed
US-20180127882-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2018-05-10 US claimed
WO-2016190865-A1 CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-12-01 WO claimed
US-8361937-B2 Corrosion inhibitor compositions comprising reaction products of aldehydes and amides and related methods HALLIBURTON ENERGY SERVICES, INC. (US) 2013-01-29 US claimed
US-7618756-B2 Photoconductors containing chelating components XEROX CORPORATION (US) 2009-11-17 US claimed
EP-1802572-B1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AG (DE) 2009-04-22 EP claimed
US-20080220352-A1 Photoconductors containing chelating components XEROX CORPORATION 2008-09-11 US claimed
US-20060074084-A1 Inhibitors of soluble adenylate cyclase BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-04-06 US claimed
US-6896931-B2 Methods of forming polybenzimidazole coating film and of forming film CLARIANT FINANCE (BVI) LIMITED (VG) 2005-05-24 US claimed
EP-1441015-A1 METHODS OF FORMING POLYBENZIMIDAZOLE COATING FILM AND OF FORMING FILM CLARIANT INTERNATIONAL LTD. (CH) 2004-07-28 EP claimed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP claimed
US-20040028824-A1 Methods of forming polybenzimidazole coating film and of forming film PBI ADVANCED MATERIALS CO., LTD. (JP) 2004-02-12 US claimed
US-5886118-A ACTIVATING THE ADDITIONAL HOMO- OR COPOLYMERIZATION IN SOLVENT AND A METAL CATALYST WITH AN INITIATOR SELECTED FROM THE GROUP CONSISTING OF SULFONYL HALIDES, HALOPROPIONITRILES, MONOADDUCTS DERIVED FROM SULFONYL HALIDES AND ACRYLONITRILE CASE WESTERN RESERVE UNIVERSITY (US) 1999-03-23 US claimed
EP-0872493-A2 Process for polymerizing acrylonitrile Case Western Reserve University (US) 1998-10-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074084-A1 Inhibitors of soluble adenylate cyclase ADCY1, ADCY2, ADCY5 ALOX15 850/4885THRB 503/4885LMNA 3432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.